Related Experiment Video
Updated: Jan 9, 2026

03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.3K
Non-Invasive Biomarkers for Eosinophilic Esophagitis: Latest Developments and Future Directions
Serena Marulo1, Alessandra Macrì1, Peppino Mirabelli1
1Clinical and Translational Research Unit, Santobono-Pausilipon Children's Hospital, 80129 Naples, Italy.
Journal of Clinical Medicine
|December 11, 2025
Summary
Eosinophilic esophagitis (EoE) is a chronic esophageal inflammation. Researchers are exploring non-invasive biomarkers to improve diagnosis and monitoring, reducing patient discomfort and healthcare costs.
Area of Science:
- Gastroenterology
- Immunology
- Allergy
Background:
- Eosinophilic esophagitis (EoE) is an emerging chronic esophageal inflammatory disease.
- It is a multifactorial disorder involving genetic, environmental, and immune factors, leading to type 2 inflammation.
- Symptoms like dysphagia and heartburn can mimic gastroesophageal reflux disease, complicating diagnosis.
Purpose of the Study:
- To review and categorize promising non-invasive or minimally invasive biomarkers for EoE.
- To enable earlier detection and reduce patient discomfort associated with current diagnostic methods.
- To guide personalized treatment strategies for EoE.
Main Methods:
- Literature review synthesizing current findings on EoE biomarkers.
- Categorization of biomarkers based on biological source (e.g., blood, saliva, stool).
- Analysis of biomarker potential for diagnosis, treatment assessment, and remission monitoring.
Main Results:
- Current EoE diagnosis requires invasive endoscopic biopsies.
- Repeated endoscopic procedures for diagnosis and monitoring are burdensome for patients and costly.
- Novel biomarkers are being investigated to offer less invasive diagnostic and monitoring alternatives.
Conclusions:
- Development of non-invasive biomarkers is crucial for improving EoE management.
- Biomarkers can potentially reduce the need for repeated endoscopies, enhancing patient experience.
- Identifying reliable biomarkers will support earlier diagnosis and personalized therapeutic approaches for EoE.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Barrett Esophagus-II: Clinical Manifestations and Management
738
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
738
Ultrasound II: Endoscopic Ultrasound and FibroScan
499
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
499

